Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y013576 | — |
No additional AE; Provider calling to reporting temperature excursion. One dose of PROQUAD was administered after undergoing supported excursion. No clinical side effects noted. No additional AE, no PQC. No additional information. ? Names of vaccines inv; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 12-Jan-2026, the patient was vaccinated with improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y013576, expiration date: 03-Feb-2026) 0.5 mL for prophylaxis. No adverse event was reported. The vaccine underwent a temperature excursion of -12.3 degree Celsius for 38 minutes.